NM-2-AI

Add links
Source: Wikipedia, the free encyclopedia.
NM-2-AI
Clinical data
Other namesN-Methyl-2-aminoindane; AM-80
Legal status
Legal status
Identifiers
  • N-Methyl-2,3-dihydro-1H-inden-2-amine
JSmol)
  • CNC2CC1=CC=CC=C1C2
  • InChI=1S/C10H13N/c1-11-10-6-8-4-2-3-5-9(8)7-10/h2-5,10-11H,6-7H2,1H3
  • Key:SXWZQUCTTOBHJT-UHFFFAOYSA-N

NM-2-AI (N-methyl-2-aminoindane) is a

2-aminoindane
.

Pharmacology

Pharmacodynamics

NM-2-AI acts as a highly

releasing agent in vitro.[3]

NM-2AI has high affinity (2.4 µM

5-HT2A (5.4 µM Ki) receptors[4]

Pharmacokinetics

Metabolism

Scientists performed a study on N-methyl-2-aminoindane (NM2AI) metabolism

2-AI were also detected by LC-HRMS in the hair and blood [5]

References

  1. ^ "N-methyl-2-AI". Cayman Chemical. Retrieved 27 June 2015.
  2. PMID 7190613
    .
  3. S2CID 28786127
    .
  4. ^ "N-METHYLINDAN-2-AMINE". Inxight Drugs. National Center for Advancing Translational Sciences (NCATS), U.S. National Institutes of Health.
  5. PMID 32860694
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=NM-2-AI&oldid=1180689883"